Researchers found that higher maternal BMI in early pregnancy and before delivery were associated with an increased risk of ALL in female offspring, but there were no such associations for male ...

Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful chemotherapy-induced peripheral neuropathy, researchers found.

The median progression-free survival and overall survival were not reached. Tislelizumab and low-dose nab-paclitaxel could be a treatment option for patients with extensive, very high-risk non ...

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

Adding atezolizumab to adjuvant chemotherapy does not improve outcomes in patients with stage II-III TNBC, phase 3 data suggest.

Provider prioritization of relationship-building alongside explanations could foster trust and facilitate open information exchange, supporting informed decisions,” researchers wrote.

Some patients who had disease progression after stopping larotrectinib achieved a response after resuming larotrectinib.

Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...